These data provide further evidence for the effects of AZD5363 on tumour vasculature and previous reports that PI3K/Akt inhibitors can reduce the proliferation of HUVEC cells in vitro are consistent with this observation (Varma et al, 2005). The gene discussed is AKT1; the disease is neoplasm.